India delays big exports of AstraZeneca shot as infections surge, say sources

India delays big exports of AstraZeneca shot as infections surge, say sources
Reuters
Share
Font Size
Save
Comment
Synopsis

COVAX has so far received 17.7 million AstraZeneca doses from SII, of the 60.5 million doses India has shipped in total, and many countries are relying on the programme to immunise their citizens.

Agencies
India's foreign ministry and SII, the world's biggest vaccine manufacturer, did not immediately reply to requests for comment.
India has put a temporary hold on all major exports of the coronavirus vaccine made by the Serum Institute of India (SII) to meet demand at home as infections rise, two sources told Reuters.

The move will also affect supplies to the GAVI/WHO-backed COVAX vaccine-sharing facility through which more than 180 countries are expected to get doses, one of the sources said.

COVAX has so far received 17.7 million AstraZeneca doses from SII, of the 60.5 million doses India has shipped in total, and many countries are relying on the programme to immunise their citizens.

There has been no vaccine export from India since Thursday, the foreign ministry's website https://www.mea.gov.in/vaccine-supply.htm shows, as the country expands its own immunisation effort.

"Everything else has taken a backseat, for the time being at least," said one of the sources. Both sources had direct knowledge of the matter, but declined to be named as the discussions are not public.

"No exports, nothing till the time the India situation stabilises. The government won't take such a big chance at the moment when so many need to be vaccinated in India."

India's foreign ministry and SII, the world's biggest vaccine manufacturer, did not immediately reply to requests for comment.

Read More News on

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

3 Comments on this Story

debo chakraborti37 seconds ago
This will have a huge jolt on India's Vaccine Diplomacy Program..Hope things get back on track soon!
Pratik Biyani26 minutes ago
sure.. companies are free to make it by themselves or thru some other country then! most welcome.
Ron 31 minutes ago
that's vaccine may be manufactured in India but it's developed by Oxford.....u have no right to block it from accessing it... first u take away the credit of Oxford efforts and also nill gates huge donations

ETPrime stories of the day

Read before you invest. Insights on AstraZeneca Pharma India Ltd.. Explore Now